Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Myderm Bite Relief

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Ointment
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
July 29, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Ointment
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
July 29, 2025
Manufacturer
Inspec Solutions LLC.
Registration number
M017
NDC root
72667-019
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

MyDerm Bite Relief is a medication designed to provide temporary relief from the pain and itching that can occur due to insect bites. If you've ever experienced discomfort from a bug bite, this product may help soothe those irritating symptoms, allowing you to feel more comfortable.

Uses

If you're dealing with discomfort from insect bites, this medication can provide temporary relief from both pain and itching. It's designed to help soothe your skin and make you feel more comfortable after an annoying encounter with bugs.

Rest assured, there are no concerns about teratogenic effects (which means it won't cause birth defects) associated with this medication. You can use it without worrying about these specific risks.

Dosage and Administration

If you are an adult or a child aged 2 years and older, you can apply this medication to the affected area up to 3 to 4 times a day. Make sure to follow this guideline to ensure the best results.

For children under 2 years of age, it’s important to consult a physician (doctor) before using this medication. This will help ensure safety and proper care for younger children.

What to Avoid

It's important to be aware of certain guidelines when using this medication. You should stop using it and consult your doctor if your condition worsens, if symptoms last longer than 7 days, or if they improve and then return within a few days.

Currently, there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. Always prioritize your health and seek medical advice if you have any questions or concerns.

Side Effects

When using this product, it's important to remember that it is for external use only, and you should avoid contact with your eyes. If your condition worsens, or if your symptoms last more than 7 days or improve and then return within a few days, you should stop using the product and consult a doctor.

Warnings and Precautions

This product is intended for external use only, so please avoid applying it to your eyes. It's important to keep it out of reach of children. If a child accidentally swallows it, seek medical help or contact a Poison Control Center immediately.

If your condition worsens, or if your symptoms last longer than 7 days or improve and then return within a few days, stop using the product and consult your doctor. Your health and safety are important, so don’t hesitate to reach out for help if you have any concerns.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that the safety of benzocaine, a common topical anesthetic, has not been established. Due to potential risks to the fetus, benzocaine is generally not recommended for use during pregnancy.

Before using any products containing benzocaine, you should consult your physician to discuss your specific situation and any potential risks. Your healthcare provider can help you find safer alternatives if needed.

Lactation Use

If you are breastfeeding and considering using MyDerm Bite Relief (benzocaine ointment), it's important to note that the drug insert does not provide specific information about its use during nursing. This means there are no established guidelines or safety data regarding how this medication may affect breast milk or your nursing infant.

As always, it's best to consult with your healthcare provider before using any medication while breastfeeding. They can help you weigh the potential benefits and risks to ensure the safety of both you and your baby.

Pediatric Use

When using this medication for children aged 2 years and older, you should apply it to the affected area no more than 3 to 4 times a day. If your child is under 2 years old, it's important to consult a physician (doctor) before use.

Always keep this medication out of reach of children. If your child accidentally swallows it, seek medical help or contact a Poison Control Center immediately. Your child's safety is a priority, so following these guidelines is essential.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that healthcare providers may not have tailored guidelines for elderly patients, which can be important given the unique health considerations that often come with aging.

If you or a caregiver are considering this medication for an older adult, it’s essential to consult with a healthcare professional. They can provide personalized advice and monitor for any potential issues, ensuring that the treatment is safe and effective for the individual’s specific health needs.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment and what steps to take for your safety.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team has a complete understanding of your health and can provide the best care possible.

Always feel free to ask questions about how different medications might work together or affect any tests you may need. Your safety and well-being are the top priority, and discussing your medications helps to avoid any potential issues.

Storage and Handling

To ensure the safety and effectiveness of the product, store it at room temperature, away from direct sunlight and moisture. It's important to keep the product out of reach of children to prevent accidental ingestion. If the product is swallowed, seek medical assistance or contact a Poison Control Center immediately for guidance. Taking these precautions will help you use the product safely and effectively.

Additional Information

You can apply this product to the affected area 3 to 4 times daily if you are an adult or a child aged 2 years and older. If your child is under 2 years old, it's important to consult a physician before use.

While using this product, be careful to avoid contact with your eyes. If your condition worsens, or if symptoms last more than 7 days or return after clearing up, stop using the product and consult a doctor. Always keep it out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately.

FAQ

What is MyDerm Bite Relief used for?

MyDerm Bite Relief provides temporary relief of pain and itching associated with insect bites.

How should I use MyDerm Bite Relief?

For adults and children 2 years of age and older, apply to the affected area not more than 3 to 4 times daily. Consult a physician for children under 2 years of age.

Are there any contraindications for using MyDerm Bite Relief?

There are no specific contraindications mentioned, but benzocaine is contraindicated in pregnancy due to potential risks to the fetus.

What should I do if my condition worsens while using this product?

Stop use and ask a doctor if your condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.

Is MyDerm Bite Relief safe to use during pregnancy?

The safety of benzocaine during pregnancy has not been established. Consult a physician before use if you are pregnant or planning to become pregnant.

What precautions should I take when using MyDerm Bite Relief?

For external use only, avoid contact with the eyes, and keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

What should I do if I accidentally swallow MyDerm Bite Relief?

If swallowed, get medical help or contact a Poison Control Center immediately.

Packaging Info

Below are the non-prescription pack sizes of Myderm Bite Relief (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Myderm Bite Relief.
Details

Drug Information (PDF)

This file contains official product information for Myderm Bite Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

MyDerm Bite Relief is a topical formulation designed to alleviate discomfort associated with insect bites. The product is presented in a cream dosage form, facilitating easy application to affected areas. It is characterized by its specific blend of active and inactive ingredients, which work synergistically to provide relief. The formulation is designed for external use only and is intended for application on intact skin.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with insect bites.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 2 years of age, it is advised to consult a physician prior to use to determine the appropriate course of action and ensure safety.

Contraindications

There are no specified contraindications for the use of this product. However, it is advised to discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes during application. In the event of accidental contact, immediate rinsing with water is recommended.

It is crucial to keep this product out of the reach of children. In cases of ingestion, patients should seek medical assistance or contact a Poison Control Center without delay.

Patients should be instructed to discontinue use and consult a healthcare provider if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Monitoring for these signs is essential to ensure patient safety and effective management of their condition.

Side Effects

Patients should be aware that this product is for external use only and must be used with caution to avoid contact with the eyes.

In clinical practice, it is advised that patients stop using the product and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. These precautions are essential to ensure the safety and efficacy of the treatment.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Myderm Bite Relief (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Myderm Bite Relief.
Details

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area no more than 3 to 4 times daily. For children under 2 years of age, consultation with a physician is advised prior to use.

It is important to keep the medication out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of benzocaine during pregnancy has not been established. Benzocaine is contraindicated in pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a physician before using this medication to discuss potential risks and benefits.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for MyDerm Bite Relief (benzocaine ointment). Therefore, healthcare professionals should exercise caution when recommending this product to lactating mothers. The potential effects on breastfed infants have not been established, and the excretion of benzocaine in breast milk is not documented. It is advisable for lactating mothers to consult with their healthcare provider before using this product.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Common symptoms may include, but are not limited to, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may involve the following steps:

  1. Assessment: Conduct a thorough evaluation of the patient's clinical status, including vital signs and level of consciousness.

  2. Supportive Care: Provide symptomatic treatment as necessary, which may include intravenous fluids, oxygen supplementation, or medications to stabilize the patient's condition.

  3. Decontamination: If the overdose is recent and the patient is alert, activated charcoal may be administered to limit further absorption of the substance.

  4. Consultation: Engage with a poison control center or toxicology specialist for guidance on specific antidotes or advanced interventions, if applicable.

Healthcare professionals should remain vigilant and document all findings and interventions in the patient's medical record. Continuous monitoring and reassessment are crucial to ensure patient safety and effective management of the overdose situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should also be instructed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. This guidance is essential to ensure patient safety and effective management of their condition.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at room temperature to maintain its efficacy and safety.

To ensure safety, the product should be kept out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately. Special handling precautions should be observed to prevent misuse and ensure the well-being of all users.

Additional Clinical Information

Patients aged 2 years and older are advised to apply the product to the affected area no more than 3 to 4 times daily. For children under 2 years of age, consultation with a physician is recommended prior to use.

Clinicians should counsel patients to avoid contact with the eyes while using the product. Patients are instructed to discontinue use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, the product should be kept out of reach of children, and immediate medical assistance or contact with a Poison Control Center is necessary if the product is swallowed.

Drug Information (PDF)

This file contains official product information for Myderm Bite Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Myderm Bite Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.